 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 05/21/2024 |
$15.13 |
$15.13 |
$15.13 |
$15.13 |
0 | | 05/22/2024 |
$15.13 |
$15.13 |
$15.13 |
$15.13 |
0 | | 05/23/2024 |
$15.13 |
$15.13 |
$15.13 |
$15.13 |
0 | | 05/24/2024 |
$15.13 |
$15.13 |
$15.13 |
$15.13 |
0 | | 05/28/2024 |
$15.13 |
$15.13 |
$15.13 |
$15.13 |
0 |
|
|
| Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company. Co. does not have any ongoing research or development activities and is seeking potential acquirers for its remaining preclinical and clinical assets. It is entitled to receive payments related to its sale of ONIVYDE to Ipsen S.A. and also its contingent payments related to its sale of MM-121 and MM-111 to Elevation Oncology, Inc. These payments are payable by Ipsen upon approval by the U.S. Food and Drug Administration (FDA) of Onivyde for certain additional clinical indications. ONIVYDE is approved by FDA to market as a first-line treatment of metastatic adenocarcinoma on the pancreas. | |
|
Merrimack Pharmaceuticals (MACK) has the following price history information. Looking back at MACK historical stock prices for the last five trading days, on May 21, 2024, MACK opened at $15.13, traded as high as $15.13 and as low as $15.13, and closed at $15.13. Trading volume was a total of 0 shares. On May 22, 2024, MACK opened at $15.13, traded as high as $15.13 and as low as $15.13, and closed at $15.13. Trading volume was a total of 0 shares. On May 23, 2024, MACK opened at $15.13, traded as high as $15.13 and as low as $15.13, and closed at $15.13. Trading volume was a total of 0 shares. On May 24, 2024, MACK opened at $15.13, traded as high as $15.13 and as low as $15.13, and closed at $15.13. Trading volume was a total of 0 shares. On May 28, 2024, MACK opened at $15.13, traded as high as $15.13 and as low as $15.13, and closed at $15.13. Trading volume was a total of 0 shares.
MACK Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Merrimack Pharmaceuticals shares, starting with a $10,000 purchase of MACK, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
07/13/2015 |
|
| End date: |
05/28/2024 |
|
| Start price/share: |
$95.36 |
|
| End price/share: |
$15.13 |
|
| Starting shares: |
104.87 |
|
| Ending shares: |
433.88 |
|
| Dividends reinvested/share: |
$25.40 |
|
| Total return: |
-34.35% |
|
| Average Annual Total Return: |
-4.63% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$6,563.44 |
|
| Years: |
8.88 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
07/13/2015 |
|
| End date: |
05/28/2024 |
|
| Start price/share: |
$95.36 |
|
| End price/share: |
$15.13 |
|
| Dividends collected/share: |
$25.40 |
|
| Total return: |
-57.50% |
|
| Average Annual Total Return: |
-9.18% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$4,251.67 |
|
| Years: |
8.88 |
|
|
|
| Date |
Close |
| 05/21/2024 | $15.13 | | 05/22/2024 | $15.13 | | 05/23/2024 | $15.13 | | 05/24/2024 | $15.13 | | 05/28/2024 | $15.13 |
|
|
Free MACK Email Alerts:
